{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:13:20Z","timestamp":1793798000115,"version":"4.6.1"},"reference-count":209,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Cancer cachexia is a complex, multifactorial syndrome characterized by severe weight loss, muscle wasting, and systemic inflammation, significantly contributing to cancer-related morbidity and mortality. Signal transducer and activator of transcription 3 (STAT3) has emerged as a central mediator in the pathogenesis of this multifactorial condition. STAT3 regulates a broad range of cellular processes including inflammation, proteolysis, and mitochondrial dysfunction across multiple tissues, particularly skeletal muscle and adipose tissue. Persistent activation of STAT3 in response to tumor-derived and host-derived cytokines drives catabolic signaling cascades, disrupts anabolic pathways, and impairs energy homeostasis. Recent studies have illuminated the cross-talk between STAT3 and other signaling pathways that exacerbate cachexia-related metabolic imbalances. These findings position STAT3 not only as a critical mediator of cachexia progression but also as a promising therapeutic target. Pharmacological inhibition of STAT3 signaling has demonstrated efficacy in preclinical models, offering potential avenues for clinical intervention. This review provides a comprehensive overview of the molecular mechanisms by which STAT3 contributes to cancer cachexia and discusses emerging therapeutic strategies aimed at modulating STAT3 activity to mitigate the progression of this debilitating syndrome.<\/jats:p>","DOI":"10.3389\/fendo.2025.1608612","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:47:13Z","timestamp":1752126433000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Unraveling the role of STAT3 in Cancer Cachexia: pathogenic mechanisms and therapeutic opportunities"],"prefix":"10.3389","volume":"16","author":[{"given":"Xinyi","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengguang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00257-6","article-title":"Cancer-associated adipocytes as immunomodulators in cancer","volume":"9","author":"Wu","year":"2021","journal-title":"biomark Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jare.2023.04.018","article-title":"Immunoregulation in cancer-associated cachexia","volume":"58","author":"Wu","year":"2024","journal-title":"J Adv Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168491","article-title":"Cancer cachexia: its mechanism and clinical significance","volume":"22","author":"Nishikawa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12967-024-05266-9","article-title":"Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons","volume":"22","author":"Wang","year":"2024","journal-title":"J Transl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235590","article-title":"Cancer cachexia: new insights and future directions","volume":"15","author":"Mariean","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103689","article-title":"Update on the treatment of cancer cachexia","volume":"28","author":"Nishie","year":"2023","journal-title":"Drug Discov Today"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.318","article-title":"Differential roles of STAT3 in the initiation and growth of lung cancer","volume":"34","author":"Zhou","year":"2015","journal-title":"Oncogene"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not025","article-title":"STAT3 silencing inhibits glioma single cell infiltration and tumor growth","volume":"15","author":"Priester","year":"2013","journal-title":"Neuro Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ijbiomac.2018.05.121","article-title":"STAT3 and apoptosis challenges in cancer","volume":"117","author":"Fathi","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.03.016","article-title":"Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature","volume":"80","author":"Mohan","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00048","article-title":"Signal transducer and activator of transcription (STATs) proteins in cancer and inflammation: functions and therapeutic implication","volume":"9","author":"Loh","year":"2019","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e20190613","DOI":"10.1084\/jem.20190613","article-title":"PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation","volume":"217","author":"Damasceno","year":"2020","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-013-2084-3","article-title":"NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer","volume":"4","author":"Fan","year":"2013","journal-title":"Protein Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173107","article-title":"Targeting STAT3 in cancer and autoimmune diseases","volume":"878","author":"Gharibi","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"100220","DOI":"10.1074\/jbc.RA120.016645","article-title":"The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression","volume":"296","author":"Poria","year":"2021","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41467-024-45132-2","article-title":"The IL6\/JAK\/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer","volume":"15","author":"Amara","year":"2024","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116040","article-title":"WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin","volume":"221","author":"Yang","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","article-title":"STAT3 in the systemic inflammation of cancer cachexia","volume":"54","author":"Zimmers","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13073","article-title":"Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies","volume":"14","author":"Martin","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2019.04.006","article-title":"Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway","volume":"1864","author":"Hu","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153858","article-title":"Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway","volume":"95","author":"Shen","year":"2022","journal-title":"Phytomedicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174258","article-title":"Cancer cachexia: signaling and transcriptional regulation of muscle catabolic genes","volume":"14","author":"Rao","year":"2022","journal-title":"Cancers"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12964-021-00705-2","article-title":"Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression","volume":"19","author":"Jin","year":"2021","journal-title":"Cell Commun Signal: CCS"},{"key":"B32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT signaling: A double-edged sword of immune regulation and cancer progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)31735-0","article-title":"Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver","volume":"269","author":"Ruff-Jamison","year":"1994","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/bcr1680","article-title":"Stat3 is tyrosine-phosphorylated through the interleukin-6\/glycoprotein 130\/Janus kinase pathway in breast cancer","volume":"9","author":"Berishaj","year":"2007","journal-title":"Breast Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-11-0648","article-title":"Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer","volume":"11","author":"Chen","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2008.18","article-title":"STAT3 as a target for inducing apoptosis in solid and hematological tumors","volume":"18","author":"Al Zaid Siddiquee","year":"2008","journal-title":"Cell Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1315862110","article-title":"STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharmacol Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22438","article-title":"Non-canonical Stat3 signaling in cancer","volume":"55","author":"Srivastava","year":"2016","journal-title":"Mol Carcinog"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071610","article-title":"Targeting canonical and non-canonical STAT signaling pathways in renal diseases","volume":"10","author":"Gai","year":"2021","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.092304","article-title":"The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition","volume":"285","author":"Courapied","year":"2010","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial STAT3 supports Ras-dependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092820","article-title":"Nucleus, mitochondrion, or reticulum? STAT3 \u00e0 La carte","volume":"19","author":"Avalle","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2011.09.005","article-title":"Dynamics and non-canonical aspects of JAK\/STAT signalling","volume":"91","author":"Mohr","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101498","article-title":"Oncostatin M signaling drives cancer-associated skeletal muscle wasting","volume":"5","author":"Domaniku-Waraich","year":"2024","journal-title":"Cell Rep Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00463.2021","article-title":"IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2\/STAT3 pathway","volume":"322","author":"Ying","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: Molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12912","article-title":"A systematic review examining the relationship between cytokines and cachexia in incurable cancer","volume":"13","author":"Paval","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/spc.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4149\/bll_2019_136","article-title":"IL-6 mediated JAK\/STAT3 signaling pathway in cancer patients with cachexia","volume":"66","author":"Eskiler","year":"2019","journal-title":"Bratisl Lek Listy"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841758","article-title":"Cytokine-mediated STAT3 transcription supports ATGL\/CGI-58-dependent adipocyte lipolysis in cancer cachexia","volume":"12","author":"Gandhi","year":"2022","journal-title":"Front Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.437","article-title":"Blockade of the IL-6 trans-signalling\/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma","volume":"36","author":"Miller","year":"2017","journal-title":"Oncogene"},{"key":"B59","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41467-024-44924-w","article-title":"Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice","volume":"15","author":"Yang","year":"2024","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12346","article-title":"Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice","volume":"9","author":"Kandarian","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12561","article-title":"Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia","volume":"11","author":"Chiappalupi","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15625","article-title":"Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice","volume":"178","author":"Niu","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/s41467-023-38115-2","article-title":"TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression","volume":"14","author":"Bi","year":"2023","journal-title":"Nat Commun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1038\/s41388-020-1271-y","article-title":"Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells","volume":"39","author":"Zhao","year":"2020","journal-title":"Oncogene"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/21623945.2023.2293273","article-title":"Leptin secreted by adipocytes promotes EMT transition and endometrial cancer progression via the JAK2\/STAT3 signalling pathway","volume":"13","author":"Shen","year":"2024","journal-title":"Adipocyte"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/ng0996-95","article-title":"Leptin activation of Stat3 in the hypothalamus of wild-type and ob\/ob mice but not db\/db mice","volume":"14","author":"Vaisse","year":"1996","journal-title":"Nat Genet"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1593\/neo.13706","article-title":"The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis","volume":"15","author":"Chang","year":"2013","journal-title":"Neoplasia"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17224","article-title":"The role of interleukin-6 family cytokines in cancer cachexia","volume":"291","author":"Agca","year":"2024","journal-title":"FEBS J"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201607052","article-title":"STAT3 promotes IFN\u03b3\/TNF\u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner","volume":"9","author":"Ma","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"C487","DOI":"10.1152\/ajpcell.00112.2017","article-title":"Acute myotube protein synthesis regulation by IL-6-related cytokines","volume":"313","author":"Gao","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","article-title":"The central role of hypothalamic inflammation in the acute illness response and cachexia","volume":"54","author":"Burfeind","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nm1071","article-title":"Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity","volume":"10","author":"Mori","year":"2004","journal-title":"Nat Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13252","article-title":"SPSB1-mediated inhibition of TGF-\u03b2 receptor-II impairs myogenesis in inflammation","volume":"14","author":"Li","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/JES.0b013e3181f44f11","article-title":"Interleukin 6 as a key regulator of muscle mass during cachexia","volume":"38","author":"Carson","year":"2010","journal-title":"Exerc Sport Sci Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK","volume":"304","author":"White","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.11.005","article-title":"Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling","volume":"4","author":"Steinberg","year":"2006","journal-title":"Cell Metab"},{"key":"B80","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.abb.2016.04.015","article-title":"AMP-activated kinase \u03b12 deficiency protects mice from denervation-induced skeletal muscle atrophy","volume":"600","author":"Guo","year":"2016","journal-title":"Arch Biochem Biophys"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2010.11.030","article-title":"Regulation of AMPK by the ubiquitin proteasome system","volume":"178","author":"Zungu","year":"2011","journal-title":"Am J Pathol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.70057","article-title":"AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes","volume":"71","author":"Nakashima","year":"2007","journal-title":"Biosci Biotechnol Biochem"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3656","article-title":"STAT3 signaling controls satellite cell expansion and skeletal muscle repair","volume":"20","author":"Tierney","year":"2014","journal-title":"Nat Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1289537","article-title":"Ubiquitin-proteasome pathway in skeletal muscle atrophy","volume":"14","author":"Pang","year":"2023","journal-title":"Front Physiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e202302503","DOI":"10.26508\/lsa.202302503","article-title":"STAT3 inhibition recovers regeneration of aged muscles by restoring autophagy in muscle stem cells","volume":"7","author":"Catarinella","year":"2024","journal-title":"Life Sci Alliance"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.07.041","article-title":"STAT3 regulates self-renewal of adult muscle satellite cells during injury-induced muscle regeneration","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082265","article-title":"STAT3 in skeletal muscle function and disorders","volume":"19","author":"Guadagnin","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12967-023-04369-z","article-title":"Mitochondrial dysfunction: roles in skeletal muscle atrophy","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"dmm043166","DOI":"10.1242\/dmm.043166","article-title":"HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia","volume":"13","author":"Huot","year":"2020","journal-title":"Dis Model Mech"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01063.2017","article-title":"Role of gp130 in basal and exercise-trained skeletal muscle mitochondrial quality control","volume":"124","author":"Fix","year":"2018","journal-title":"J Appl Physiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1096\/fj.13-240580","article-title":"Skeletal muscle glycoprotein 130\u2019s role in Lewis lung carcinoma-induced cachexia","volume":"28","author":"Puppa","year":"2014","journal-title":"FASEB J"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-021-01498-3","article-title":"Insulin\/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases","volume":"70","author":"Salminen","year":"2021","journal-title":"Inflammation Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1158\/1078-0432.Ccr-16-0495","article-title":"Molecular pathways: cachexia signaling-A targeted approach to cancer treatment","volume":"22","author":"Miyamoto","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620013114","article-title":"Specific targeting of TGF-\u03b2 family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00541.2024","article-title":"Role of TGF-\u03b2\/SMAD\/YAP\/TAZ signaling in skeletal muscle fibrosis","volume":"328","author":"Gallardo","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/843743","article-title":"Tyrosine 705 phosphorylation of STAT3 is associated with phenotype severity in TGF\u03b21 transgenic mice","volume":"2015","author":"Guadagnin","year":"2015","journal-title":"BioMed Res Int"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114802","article-title":"Understanding the relationship between cancer associated cachexia and hypoxia-inducible factor-1","volume":"163","author":"Muthamil","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00090.2016","article-title":"Increased hypoxia-inducible factor-1\u03b1 in striated muscle of tumor-bearing mice","volume":"312","author":"Devine","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13795","article-title":"Carnosol attenuated atrophy of C2C12 myotubes induced by tumour-derived exosomal miR-183-5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration","volume":"131","author":"Kuang","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e92966","DOI":"10.1371\/journal.pone.0092966","article-title":"Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation","volume":"9","author":"Tsoli","year":"2014","journal-title":"PloS One"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216343","article-title":"STAT3 signalling drives LDH up-regulation and adiponectin down-regulation in cachectic adipocytes","volume":"24","author":"Mannelli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.11.005","article-title":"Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity","volume":"16","author":"Derecka","year":"2012","journal-title":"Cell Metab"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175040","article-title":"Inhibition of STAT3 enhances UCP1 expression and mitochondrial function in brown adipocytes","volume":"926","author":"Song","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-00992-y","article-title":"AMPK as a mediator of tissue preservation: time for a shift in dogma","volume":"20","author":"Langer","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.06.020","article-title":"Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia","volume":"31","author":"Ji","year":"2023","journal-title":"Mol Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.05.023","article-title":"STAT3 suppresses Wnt\/\u03b2-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis","volume":"111","author":"Cantwell","year":"2018","journal-title":"Cytokine"},{"key":"B108","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpainsymman.2013.02.016","article-title":"Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis","volume":"47","author":"Van Lancker","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.01.8010","article-title":"Systematic review of the treatment of cancer-associated anorexia and weight loss","volume":"23","author":"Yavuzsen","year":"2005","journal-title":"J Clin Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.critrevonc.2015.12.008","article-title":"Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review","volume":"99","author":"Tarricone","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41467-023-37169-6","article-title":"Structural insights into the mechanism of leptin receptor activation","volume":"14","author":"Saxton","year":"2023","journal-title":"Nat Commun"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/nu16081171","article-title":"Anorexia-induced hypoleptinemia drives adaptations in the JAK2\/STAT3 pathway in the ventral and dorsal hippocampus of female rats","volume":"16","author":"Targa","year":"2024","journal-title":"Nutrients"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-221037","article-title":"Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin","volume":"144","author":"M\u00fcnzberg","year":"2003","journal-title":"Endocrinology"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0303992101","article-title":"Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation","volume":"101","author":"Gao","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-2095","article-title":"Ghrelin induces leptin resistance by activation of suppressor of cytokine signaling 3 expression in male rats: implications in satiety regulation","volume":"155","author":"Heldsinger","year":"2014","journal-title":"Endocrinology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e23675","DOI":"10.4161\/jkst.23675","article-title":"JAK-STAT and feeding","volume":"2","author":"Ladyman","year":"2013","journal-title":"Jakstat"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.7.8225","article-title":"Leptin and tumor necrosis factor-alpha induce the tyrosine phosphorylation of signal transducer and activator of transcription proteins in the hypothalamus of normal rats in vivo","volume":"142","author":"Rizk","year":"2001","journal-title":"Endocrinology"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.061034298","article-title":"Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity","volume":"98","author":"Lambert","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1159\/000108280","article-title":"Regulation of food intake by inflammatory cytokines in the brain","volume":"86","author":"Buchanan","year":"2007","journal-title":"Neuroendocrinology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1159\/000445523","article-title":"Hypothalamic phosphodiesterase 3B pathway mediates anorectic and body weight-reducing effects of insulin in male mice","volume":"104","author":"Sahu","year":"2017","journal-title":"Neuroendocrinology"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.21-07-02413.2001","article-title":"Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation","volume":"21","author":"H\u00fcbschle","year":"2001","journal-title":"J Neurosci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1210\/rp.59.1.287","article-title":"Leptin receptor signaling and the regulation of mammalian physiology","volume":"59","author":"Myers","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"30059","DOI":"10.1074\/jbc.274.42.30059","article-title":"The role of SOCS-3 in leptin signaling and leptin resistance","volume":"274","author":"Bj\u00f8rbaek","year":"1999","journal-title":"J Biol Chem"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2008.07.043","article-title":"Hypothalamic IKKbeta\/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity","volume":"135","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/nature02440","article-title":"AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus","volume":"428","author":"Minokoshi","year":"2004","journal-title":"Nature"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.05.010","article-title":"p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin\u2019s effect on food intake","volume":"16","author":"Dagon","year":"2012","journal-title":"Cell Metab"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"11697","DOI":"10.1038\/s41598-019-48256-4","article-title":"Myeloid maturation potentiates STAT3-mediated atypical IFN-\u03b3 signaling and upregulation of PD-1 ligands in AML and MDS","volume":"9","author":"Yoyen-Ermis","year":"2019","journal-title":"Sci Rep"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.103","article-title":"PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma","volume":"31","author":"Atsaves","year":"2017","journal-title":"Leukemia"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205652","article-title":"Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients","volume":"16","author":"Yu","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2020.100020","article-title":"Desensitizing effect of cancer cachexia on immune checkpoint inhibitors in patients with advanced NSCLC","volume":"1","author":"Miyawaki","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2010.03.004","article-title":"Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3","volume":"131","author":"Brayer","year":"2010","journal-title":"Immunol Lett"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113661","article-title":"VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms","volume":"43","author":"Zhang","year":"2024","journal-title":"Cell Rep"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/nm1325","article-title":"Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity","volume":"11","author":"Kortylewski","year":"2005","journal-title":"Nat Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2020.04.017","article-title":"Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia","volume":"484","author":"Shukla","year":"2020","journal-title":"Cancer Lett"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-10-0736","article-title":"Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells","volume":"70","author":"Herrmann","year":"2010","journal-title":"Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.016","article-title":"A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory","volume":"35","author":"Siegel","year":"2011","journal-title":"Immunity"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564450","article-title":"Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance","volume":"124","author":"Gotthardt","year":"2014","journal-title":"Blood"},{"key":"B143","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4049\/jimmunol.1002067","article-title":"Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors","volume":"187","author":"Iwata-Kajihara","year":"2011","journal-title":"J Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2015.04.003","article-title":"Cachexia and sarcopenia: mechanisms and potential targets for intervention","volume":"22","author":"Argil\u00e9s","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02781-9","article-title":"JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3\/IL-10 axis","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030676","article-title":"Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity","volume":"20","author":"Padoan","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B148","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12964-020-00557-2","article-title":"Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression","volume":"18","author":"Liu","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e004219","DOI":"10.1136\/jitc-2021-004219","article-title":"Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer","volume":"10","author":"Zhu","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2226418","article-title":"Targeting crosstalk of STAT3 between tumor-associated M2 macrophages and Tregs in colorectal cancer","volume":"24","author":"Huang","year":"2023","journal-title":"Cancer Biol Ther"},{"key":"B151","doi-asserted-by":"publisher","first-page":"eadi2952","DOI":"10.1126\/scitranslmed.adi2952","article-title":"Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6\/STAT3 axis","volume":"16","author":"Neo","year":"2024","journal-title":"Sci Transl Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7759","article-title":"miR\u2212203 contributes to IL\u221217\u2212induced VEGF secretion by targeting SOCS3 in keratinocytes","volume":"16","author":"Xu","year":"2017","journal-title":"Mol Med Rep"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S430443","article-title":"Pancreatic cancer-derived exosomal miR-let-7b-5p stimulates insulin resistance in skeletal muscle cells through RNF20\/STAT3\/FOXO1 axis regulation","volume":"16","author":"Wang","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: from interferons to cytokines","volume":"282","author":"Schindler","year":"2007","journal-title":"J Biol Chem"},{"key":"B155","doi-asserted-by":"publisher","first-page":"8414","DOI":"10.1038\/s41598-018-26625-9","article-title":"eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways","volume":"8","author":"Cramer","year":"2018","journal-title":"Sci Rep"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24580","article-title":"Pancreatic cancer-induced cachexia is Jak2-dependent in mice","volume":"229","author":"Gilabert","year":"2014","journal-title":"J Cell Physiol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1097\/spc.0000000000000014","article-title":"Anti-inflammatory therapy: exploring exercise, serum-derived bovine immunoglobulin\/protein isolates, and ruxolitinib for the cancer-associated weight loss syndrome","volume":"7","author":"Jatoi","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/rco2.24","article-title":"JAK inhibitors suppress cancer cachexia-associated anorexia and adipose wasting in mice","volume":"3","author":"Arora","year":"2020","journal-title":"JCSM Rapid Commun"},{"key":"B160","doi-asserted-by":"publisher","first-page":"F84","DOI":"10.1152\/ajprenal.00603.2019","article-title":"Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney disease","volume":"319","author":"Zhang","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1225","article-title":"Jak\/Stat3 signaling promotes somatic cell reprogramming by epigenetic regulation","volume":"30","author":"Tang","year":"2012","journal-title":"Stem Cells"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N Engl J Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12867","article-title":"Sepsis induces interleukin 6, gp130\/JAK2\/STAT3, and muscle wasting","volume":"13","author":"Zanders","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0151-y","article-title":"Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis","volume":"20","author":"Madaro","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1031906","article-title":"C188-9, a specific inhibitor of STAT3 signaling, prevents thermal burn-induced skeletal muscle wasting in mice","volume":"13","author":"Ono","year":"2022","journal-title":"Front Pharmacol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"e113931","DOI":"10.1371\/journal.pone.0113931","article-title":"Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3","volume":"9","author":"Toledo","year":"2014","journal-title":"PloS One"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J Med Chem"},{"key":"B169","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semcancer.2019.09.022","article-title":"Repurposing of drugs as STAT3 inhibitors for cancer therapy","volume":"68","author":"Thilakasiri","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176429","article-title":"Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model","volume":"969","author":"Chen","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1002\/mco2.558","article-title":"Brassinin alleviates cancer cachexia by suppressing diverse inflammatory mechanisms in mice","volume":"5","author":"Yang","year":"2024","journal-title":"MedComm"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13079","article-title":"Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles","volume":"13","author":"Fan","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7676","article-title":"Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3","volume":"37","author":"Chen","year":"2023","journal-title":"Phytother Res"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7811","article-title":"Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6\/STAT3\/FoxO signaling pathway","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104871","article-title":"Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3","volume":"158","author":"Chen","year":"2020","journal-title":"Pharmacol Res"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13084","article-title":"Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway","volume":"13","author":"Wijaya","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113066","article-title":"Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway","volume":"260","author":"Chen","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176538","article-title":"Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis","volume":"974","author":"Gu","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082378","article-title":"Ursolic acid alleviates cancer cachexia and prevents muscle wasting via activating SIRT1","volume":"15","author":"Tao","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00164.2004","article-title":"The anti-inflammatory effect of exercise","volume":"98","author":"Petersen","year":"2005","journal-title":"J Appl Physiol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"R296","DOI":"10.1152\/ajpregu.00147.2019","article-title":"Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation","volume":"318","author":"Daou","year":"2020","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1995.79.5.1497","article-title":"Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production","volume":"79","author":"Drenth","year":"1995","journal-title":"J Appl Physiol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00551.2015","article-title":"Exercise-mediated IL-6 signaling occurs independent of inflammation and is amplified by training in mouse adipose tissue","volume":"119","author":"Castellani","year":"2015","journal-title":"J Appl Physiol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"295","DOI":"10.33549\/physiolres.935234","article-title":"Endurance training inhibits the JAK2\/STAT3 pathway to alleviate sarcopenia","volume":"73","author":"Yao","year":"2024","journal-title":"Physiol Res"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.880787","article-title":"Resistance training attenuates activation of STAT3 and muscle atrophy in tumor-bearing mice","volume":"12","author":"Testa","year":"2022","journal-title":"Front Oncol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/02640414.2020.1829362","article-title":"Effects of descending or ascending stair exercise on body composition, insulin sensitivity, and inflammatory markers in young Chinese women with obesity: A randomized controlled trial","volume":"39","author":"Chow","year":"2021","journal-title":"J Sports Sci"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-03927-0","article-title":"Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects","volume":"148","author":"Mavropalias","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188761","article-title":"Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression","volume":"1877","author":"Huang","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2001.0329c.xd","article-title":"Muscle-derived interleukin-6: possible biological effects","volume":"536","author":"Pedersen","year":"2001","journal-title":"J Physiol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1017\/s0007114522000575","article-title":"n-3 PUFA can reduce IL-6 and TNF levels in patients with cancer","volume":"129","author":"Guo","year":"2023","journal-title":"Br J Nutr"},{"key":"B191","doi-asserted-by":"publisher","first-page":"e1801148","DOI":"10.1002\/mnfr.201801148","article-title":"Omega-3 polyunsaturated fatty acids inhibit IL-17A secretion through decreased ICAM-1 expression in T cells co-cultured with adipose-derived stem cells harvested from adipose tissues of obese subjects","volume":"63","author":"Chehimi","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"B192","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3892\/ijmm.2021.5023","article-title":"Omega\u22123 polyunsaturated fatty acids inhibit IL\u221211\/STAT3 signaling in hepatocytes during acetaminophen hepatotoxicity","volume":"48","author":"Liu","year":"2021","journal-title":"Int J Mol Med"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3390\/nu16132044","article-title":"Omega-3 fatty acid supplementation on post-exercise inflammation, muscle damage, oxidative response, and sports performance in physically healthy adults-A systematic review of randomized controlled trials","volume":"16","author":"Fern\u00e1ndez-L\u00e1zaro","year":"2024","journal-title":"Nutrients"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1186\/s12970-020-00405-1","article-title":"The effect of Omega-3 polyunsaturated fatty acid supplementation on exercise-induced muscle damage","volume":"18","author":"Kyriakidou","year":"2021","journal-title":"J Int Soc Sports Nutr"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.105833","article-title":"Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults","volume":"102","author":"Smith","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3390\/md21070399","article-title":"The effect of omega-3 fatty acids on sarcopenia: mechanism of action and potential efficacy","volume":"21","author":"Therdyothin","year":"2023","journal-title":"Mar Drugs"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143108","article-title":"n-3 PUFA-enriched diet preserves skeletal muscle mitochondrial function and redox state and prevents muscle mass loss in mice with chronic heart failure","volume":"15","author":"Gortan Cappellari","year":"2023","journal-title":"Nutrients"},{"key":"B198","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/apnm-2018-0765","article-title":"Effects of low-dose leucine supplementation on gastrocnemius muscle mitochondrial content and protein turnover in tumor-bearing mice","volume":"44","author":"Lee","year":"2019","journal-title":"Appl Physiol Nutr Metab"},{"key":"B199","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12885-019-5448-0","article-title":"A leucine-rich diet modulates the mTOR cell signalling pathway in the gastrocnemius muscle under different Walker-256 tumour growth conditions","volume":"19","author":"Cruz","year":"2019","journal-title":"BMC Cancer"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12208","article-title":"Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions","volume":"8","author":"Hole\u010dek","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B202","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/13543780802565791","article-title":"Targeting STAT3 in cancer: how successful are we","volume":"18","author":"Yue","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2008.40.5.479","article-title":"STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination","volume":"40","author":"Jung","year":"2008","journal-title":"Exp Mol Med"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2013.12.005","article-title":"Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors","volume":"1845","author":"Siveen","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem J"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.2174\/0929867329666220819093117","article-title":"Discovery of STAT3 inhibitors: recent advances and future perspectives","volume":"30","author":"Song","year":"2023","journal-title":"Curr Med Chem"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-3407","article-title":"AKT blocks SIK1-mediated repression of STAT3 to promote breast tumorigenesis","volume":"83","author":"Sun","year":"2023","journal-title":"Cancer Res"},{"key":"B208","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/or.2022.8384","article-title":"Synergistic effects of thalidomide and cisplatin are mediated via the PI3K\/AKT and JAK1\/STAT3 signaling pathways in cervical cancer","volume":"48","author":"Liu","year":"2022","journal-title":"Oncol Rep"},{"key":"B209","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun Signal"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1608612\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T12:13:23Z","timestamp":1752149603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1608612\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":209,"alternative-id":["10.3389\/fendo.2025.1608612"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1608612","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1608612"}}